NAM QUOC BUI
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology STANFORD, CA NPI 1982994802
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology CA Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$6,766.61
- Category: General Payments
- Program years: PY2022–2024
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $6,650.68 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $3,720.00 | 2 |
| Consulting Fee | $2,610.00 | 1 |
| Food and Beverage | $285.68 | 3 |
| Travel and Lodging | $35.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,610.00 | 1 |
| Aadi Bioscience, Inc. | $2,055.00 | 1 |
| Deciphera Pharmaceuticals Inc. | $1,931.40 | 4 |
| Daiichi Sankyo Inc. | $54.28 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089404230 | Daiichi Sankyo Inc. | $54.28 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118263091 | Boehringer Ingelheim Pharmaceuticals, Inc. | $2,610.00 | 01/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1119596927 | Aadi Bioscience, Inc. | $2,055.00 | 06/01/2024 | Honoraria | Undisputed | 01/23/2026 | View at CMS |
| 1145872399 | Deciphera Pharmaceuticals Inc. | $1,665.00 | 08/17/2024 | Honoraria | Undisputed | 01/23/2026 | View at CMS |
| 1145872401 | Deciphera Pharmaceuticals Inc. | $115.70 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145872403 | Deciphera Pharmaceuticals Inc. | $115.70 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145872405 | Deciphera Pharmaceuticals Inc. | $35.00 | 08/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.